Seeking Alpha
View as an RSS Feed

Derek Lowe  

View Derek Lowe's Articles BY TICKER:
Show Summaries  |  Hide Summaries
  • Two Alzheimer's Updates (Lilly And TauRx)
    Tue, Jun. 30 LLY Comment!
  • Are Things Really Picking Up?
    Wed, Jun. 17 IBB, XBI Comment!
  • The Incomplete Response Letter
    Tue, Jun. 16 IBB, XBI 3 Comments
  • Alnylam Sues Dicerna
    Fri, Jun. 12 ALNY, DRNA Comment!
  • Four Patients. Count 'Em, Four.
    Tue, Jun. 9 SAGE 3 Comments
  • More On Axovant's IPO
    Tue, Jun. 9 AXON 10 Comments
  • Some Side Effect For An Antibody
    Mon, Jun. 1 AZN 5 Comments
  • Piling On Andrew Witty
    Fri, May 15 GSK 18 Comments
  • How Not To Handle Your Clinical Data
    Wed, May 13 OREX 11 Comments
  • Calls For Andrew Witty's Job At GlaxoSmithKline
    Wed, May 6 GSK 12 Comments
  • Market Exclusivity Is Sometimes Too Much
    Mon, Apr. 27 VRX, CPRX 3 Comments
  • A New Fifty-Year-Old Hepatitis C Drug
    Thu, Apr. 9 GILD, BMY, MRK 7 Comments
  • China's First Homegrown Pharma
    Tue, Apr. 7 Comment!
  • Sanofi Bets On Schrödinger
    Sat, Apr. 4 SNY 1 Comment
  • Biogen's Alzheimer's Data
    Fri, Mar. 20 BIIB 23 Comments
  • Gamma-Secretase Inhibitors: The Wrong Way Around?
    Mon, Mar. 9 LLY 1 Comment
  • Merck Strips Out Cubist
    Fri, Mar. 6 MRK, CBSTZ 7 Comments
  • Of Proteasome Inhibitors And PAINs
    Mon, Mar. 2 AMGN Comment!
  • All That Cash
    Wed, Feb. 25 IBB, XBI 1 Comment
  • More Price Hikes On Obscure Medication
    Fri, Feb. 20 RTRX 9 Comments
  • Are New Biopharmas Being Formed Quickly Enough?
    Mon, Jan. 26 Comment!
  • A Look At Actavis
    Thu, Jan. 22 AGN 7 Comments
  • Constellation's Situation
    Wed, Jan. 21 RHHBY Comment!
  • AbbVie Competes On Price
    Dec. 23, 2014 ABBV 16 Comments
  • AbbVie Competes On Price
    Dec. 23, 2014 ABBV 10 Comments
  • A Slight Cubist Complication
    Dec. 9, 2014 MRK 6 Comments
  • Kickbacks At Sanofi?
    Dec. 5, 2014 SNY 1 Comment
  • Amgen Claims It All
    Nov. 21, 2014 AMGN 5 Comments
  • Sanofi Beats The Drum
    Nov. 20, 2014 AZN, SNY, GSK 5 Comments
  • Bind's Attempts To Remake Chemotherapy
    Nov. 20, 2014 BIND 3 Comments
  • Marketing And R&D, Again
    Nov. 11, 2014 PFE Comment!
  • The Case Of Northwest Biotherapeutics
    Sep. 29, 2014 NWBO 70 Comments